Browsing Tag
Oppenheimer Research
1 post
Sen-Jam Pharmaceutical and KVK Tech clear final hurdle for SJP-002C, setting the stage for pivotal clinical trials
Sen-Jam Pharmaceutical and KVK Tech finalize CMC deliverables for SJP-002C, positioning the novel immunoregulator for pivotal Phase 2b/3 trials.